AMGEN INC — Director's Dealing 2012

May 1, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2012-04-27

Reporting Person: SHARER KEVIN W (Director, Chairman of the Board and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-04-27	Common Stock	A	8933	—	Acquired	119433	Direct
2012-04-28	Common Stock	F	4184	$71.64	Disposed	115249	Direct
2012-04-29	Common Stock	F	4184	$71.64	Disposed	105999	Direct
2012-04-28	Common Stock	G	5066	—	Disposed	110183	Direct
2012-04-28	Common Stock	G	5066	—	Acquired	150428	Indirect
2012-04-29	Common Stock	G	5066	—	Disposed	100933	Direct
2012-04-29	Common Stock	G	5066	—	Acquired	155494	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4392.4626	Indirect

Footnotes

F1: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/27/2014, 4/27/2015 and 4/27/2016, respectively.

F2: These shares are being transferred to the reporting person's Living Trust.

F3: These shares include the following RSUs granted under the Company's equity plans: 9,250 RSUs which fully vest on 4/28/2013; 22,750 RSUs which vest in two equal annual installments of 11,375 each commencing 4/26/2013; 60,000 RSUs which vest in two equal installments of 19,800 each on 4/25/2013 and 4/25/2014 and one installment of 20,400 on 4/25/2015; and 8,933 RSUs which vest in three installments of 2,947, 2,948 and 3,038 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis.

F4: These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.